The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension. [electronic resource]
Producer: 20061012Description: 571-9 p. digitalISSN:- 1523-6838
- Aged
- Diabetes Mellitus, Type 2 -- complications
- Diabetic Angiopathies -- blood
- Diabetic Nephropathies -- blood
- Disease Progression
- Female
- Glycation End Products, Advanced -- blood
- Humans
- Hypertension -- blood
- Lysine -- analogs & derivatives
- Male
- Middle Aged
- Multivariate Analysis
- Oxidative Stress
- Predictive Value of Tests
- Proportional Hazards Models
- Prospective Studies
- Risk Factors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.